{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:30:44Z","timestamp":1790728244359,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T00:00:00Z","timestamp":1376611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T00:00:00Z","timestamp":1376611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/eye.2013.182","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T09:36:06Z","timestamp":1376645766000},"page":"1263-1268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bevacizumab as an adjunct to vitreoretinal surgery for diabetic retinopathy in East Africa"],"prefix":"10.1038","volume":"27","author":[{"given":"G","family":"Guthrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A B","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Dhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,16]]},"reference":[{"key":"BFeye2013182_CR1","unstructured":"International Diabetes Federation. Diabetes Atlas 5th edn. International Diabetes Federation: Brussels, 2012."},{"key":"BFeye2013182_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bjo.85.8.897","volume":"85","author":"S Lewallen","year":"2001","unstructured":"Lewallen S, Courtright P . Blindness in Africa: present situation and future needs. Br J Ophthalmol 2001; 85: 897\u2013903.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2013182_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","volume":"113","author":"R Avery","year":"2006","unstructured":"Avery R, Pearlman J, Pieramici D, Rabena MD, Castellarin AA, Nasir MA et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695\u20131705.","journal-title":"Ophthalmology"},{"key":"BFeye2013182_CR4","first-page":"685","volume":"142","author":"JI Mason","year":"2006","unstructured":"Mason JI, Nixon P, White M . Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 142: 685\u2013688.","journal-title":"Ophthalmology"},{"key":"BFeye2013182_CR5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/bjo.2010.189514","volume":"95","author":"L-Q Zhao","year":"2011","unstructured":"Zhao L-Q, Zhu H, Zhao P, Hu Y . A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy. Br J Ophthalmol 2011; 95: 1216\u20131222.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2013182_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/IAE.0b013e3181a3b7ef","volume":"29","author":"P Yeh","year":"2009","unstructured":"Yeh P, Yang C, Lin Y, Chen MS, Yang CH . Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy. Retina 2009; 29: 768\u2013774.","journal-title":"Retina"},{"key":"BFeye2013182_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00417-010-1303-3","volume":"248","author":"R di Lauro","year":"2010","unstructured":"di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR . Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010; 248: 785\u2013791.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2013182_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/eye.2011.149","volume":"25","author":"R Pokroy","year":"2011","unstructured":"Pokroy R, Desai UR, Du E, Li Y, Edwards P . Bevacizumab prior to vitrectomy for diabetic traction retinal detachment. Eye 2011; 25: 989\u2013997.","journal-title":"Eye"},{"key":"BFeye2013182_CR9","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen F, Burau H, Hansen L, Bach M . Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg Visual Acuity Test. Invest Ophthalmol Vis Sci 2006; 47: 1236\u20131240.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2013182_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/bjo.2008.151233","volume":"93","author":"R da","year":"2009","unstructured":"da R, Lucena D, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo-Pontes LL et al. Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra Study). Br J Ophthalmol 2009; 93: 688\u2013691.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2013182_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bjo.2007.124495","volume":"92","author":"D Yorston","year":"2008","unstructured":"Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D . Predictive clinical features and outcomes of vitrectomy for proliferative dic retinopathy. Br J Ophthalmol 2008; 92: 365\u2013368.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2013182_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2010.1111","volume":"304","author":"X Zhang","year":"2010","unstructured":"Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010; 304: 649\u2013656.","journal-title":"JAMA"},{"key":"BFeye2013182_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/bjo.2008.140301","volume":"93","author":"S Lewallen","year":"2009","unstructured":"Lewallen S, Mousa A, Bassett K, Courtright P . Cataract surgical coverage remains lower in women. Br J Ophthalmol 2009; 93: 295\u2013298.","journal-title":"Br J Ophthalmol"}],"updated-by":[{"DOI":"10.1038\/eye.2013.295","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2013182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2013182","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2013182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:19:30Z","timestamp":1684430370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2013182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,16]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFeye2013182"],"URL":"https:\/\/doi.org\/10.1038\/eye.2013.182","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/eye.2013.295","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,16]]},"assertion":[{"value":"22 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}